Medications

Tuberculosis vaccine being tested in Phase II trial

The only tuberculosis vaccine currently available is already over 90 years old - and is unsatisfactory in terms of its effectiveness. Although it protects young children against developing tuberculosis, it quickly loses its ...

Diseases, Conditions, Syndromes

Scientists identify nearly 200 potential tuberculosis drug targets

Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Diseases, Conditions, Syndromes

Low-cost TB test means quicker, more reliable diagnosis for patients

(Medical Xpress)—A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world's deadliest diseases, enabling health care providers to report results to patients within ...

Medications

Oral deucravacitinib benefits patients with lupus

Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus. A recent phase 2 clinical trial published in Arthritis & Rheumatology has ...

Psychology & Psychiatry

People respond to immediate emotions in charitable giving

(Medical Xpress) -- When considering giving money to humanitarian crises people often donate in response to events that grab their immediate emotions, according to a recent study by CU-Boulder psychology professor Leaf Van ...

Medical research

Reinvigorating the clinical drug pipeline for TB

A research team led by scientists from the Broad Institute has uncovered a novel group of chemical inhibitors that can kill the bacteria that causes tuberculosis (TB). Importantly, these chemical compounds take aim at a previously ...

page 15 from 40